Influenza C virus is immunologically unrelated to influenza A or B virus. However, because of morphological and biochemical similarities, influenza C has been considered as a member of the orthomyxovirus group (12) . The similarities include the segmented genome structure (7, 8, 20, 22 ) and the types of major structural polypeptides (7, 11, 16) . On the other hand, influenza C viruses exhibit several characteristic features which distinguish them from other orthomyxoviruses, including a different erythrocyte receptor (9) and a receptor-destroying enzyme which does not liberate sialic acid from well-known substrates (11) . The carbohydrate composition of the virion glycoproteins is also distinct for influenza C virions, and sialic acid has been identified in influenza C but not in influenza A virions (16) (17) (18) . In addition, influenza C differs in biological parameters such as host range and optimal growth temperatures (12) , as well as in some aspects of viral envelope morphology (1, 7, 15) . Virtually no information has been obtained concerning the molecular events in influenza C virus replication, which has been due in large part to the lack of suitable cell culture systems. Therefore, some uncertainty remains concerning the classification of the virus, and it has been provisionally classified as a separate genus.
In contrast to paramyxoviruses, influenza A and B viruses require nuclear functions of the host cell for their replication (4, 6, 21, 23, 24) .
Inhibitors such as a-amanitin (a-A) or actinomycin D (AMD) block replication if added at an early stage of the growth cycle, and it has been shown that DNA-dependent RNA polymerase II is required for virus replication (14, 25) . Using a chicken kidney (CK) cell culture system that we have recently described (19) , we have determined that influenza C virus replication is also dependent on such a host cell function.
To examine the effect of AMD and a-A on virus yield, CK cells infected with influenza C/ JHB/1/66 virus (C/1/66) were incubated at 330C and maintained with different concentrations of drugs in the culture medium from 1 to 24 h postinfection (p.i.). The medium was harvested 24 h p.i, and assayed for infectious virus and hemagglutinin. The effect of AMD on the yield of influenza C/1/66 in CK cells was also tested when the drug was added to the culture medium at different times p.i. cluded for comparison. As described for other cell systems (3, 4, 10) , the AMD-sensitive period of influenza A virus replication in CK cells was much shorter than that observed for influenza C. Figure 1 shows tural viral polypeptide (NS) is tentatively identified in front of the M protein in lanes 2 and 3; its synthesis was also inhibited when AMD was added at early times p.i. (lanes 4 and 5) . Thus, the drug-sensitive phase in the replication cycle is paralleled by the time during which viral protein synthesis is sensitive to inhibitors.
UV light pretreatment of the host cell is also very effective in suppressing influenza A virus replication (4) . Confluent monolayers of CK cells were irradiated for different times and subsequently infected with 20 PFU of influenza C/1/ 66 or influenza A/WSN per cell. After a 1-h adsorption period, unadsorbed virus was removed and medium was added. The virus yield was tested by hemagglutinin titration of the culture medium at 24 h p.i. Figure 2 shows that influenza C and influenza A virus replication were similar in sensitivity to UV light pretreatment of the host cell. In contrast, when we compared the sensitivity of Newcastle disease virus replication to UV light pretreatment, using the same batch of CK cells, we observed a >10-fold-lower sensitivity than that found with influenza C (data not shown).
The present results indicate that influenza C viruses are as sensitive to AMD and a-A, as are influenza A and B. Since the replication cycle of influenza C viruses is slower than that of influenza A/WSN (19), it is not surprising that the inhibitor-sensitive phase of its replication cycle is also of longer duration. Previously it has been observed that influenza C antigens occur in nuclei of infected cells (2), a finding which also resembles results with other orthomyxoviruses.
Recent evidence indicates that RNA molecules synthesized by the host cell nuclear RNA polymerase II are required for influenza A virus transcription in vivo, and their synthesis is probably the function which is inhibited by a-A (6, 21) . Further, the 5' cap of the primer RNA is transferred to the viral mRNA during the transcription process. Since RNA splicing also occurs with an in vitro transcription system, using the virion RNA polymerase and globin mRNA as the donor of the cap structure (21) , it is likely that influenza A virion proteins possess the enzymatic activities involved in this splicing event.
If the host cell function is of a similar nature in influenza C and influenza A virus-infected cells, it would follow that influenza C virions also possess enzymes which splice host cell RNA primers to viral transcripts.
The present results support the conclusion that influenza C virus resembles other orthomyxoviruses in the molecular events involved in virus replication. However, much more information is needed before the molecular biology of influenza C virus is thoroughly understood.
